News

The U.S. House of Representatives today advanced the bipartisan spending bill with several PBM reforms. Mark Blum, managing director of the PBM Accountability Project, issued the following statement: “Today’s House vote advances long-overdue PBM reforms that rein in abusive corporate middlemen practices, marking a critical step toward making healthcare more affordable for Americans. The Senate must now act without delay to put patients over profiteers and send this package t

Congressional leaders released a bipartisan spending bill with several key provisions to lower out-of-pocket costs for prescriptions, increase transparency, and support patients and independent pharmacies that pharmacy benefit managers (PBMs) have long taken advantage of. Mark Blum, managing director of the PBM Accountability Project, issued the following statement:   “We are pleased to see Congress put forward a spending package that finally begins to take on the most power

President Trump recently called upon Congress to enact “The Great Healthcare Plan ,” legislation aimed at reducing healthcare costs for Americans, in part, by targeting the practices of big health insurance companies and their affiliated pharmacy benefit managers (PBMs). PBM Accountability Project Managing Director Mark Blum issued the following statement:    “We commend the Trump Administration for insisting that Congress make healthcare affordability a priority in 2026. We

As 2025 comes to a close, President Trump announced his Administration’s plans to convene health insurance CEOs in an effort to address their role in driving up healthcare costs for the American people. PBM Accountability Project Managing Director Mark Blum issued the following statement:   “We are pleased to see President Trump and his Administration’s attention on the corporate insurers and PBMs that currently dominate the healthcare system and play a significant role in dr

U.S. Senators Ron Wyden (D-OR) and Mike Crapo (R-ID), along with nearly 20 of their colleagues, on Dec. 4  introduced  the Pharmacy Benefit Manager (PBM) Price Transparency and Accountability Act  to “fix market distortions and increase transparency in federal prescription drug programs to lower patient costs at the pharmacy counter.” Mark Blum, managing director of the PBM Accountability Project, issued the following statement:  “We applaud Senators Crapo, Wyden and their bi

The PBM industry’s lobbying arm is reportedly working to avoid new federal regulations, suggesting instead that PBMs police themselves....

The House Committee on Oversight and Government Reform Chairman James Comer (R-KY) recently announced  an expanding investigation into...

The Senate HELP Committee today held a hearing entitled, “Making Health Care Affordable: Solutions to Lower Costs and Empower Patients.”...

Representative Buddy Carter (R-GA), along with 11 bipartisan members of Congress, today introduced the PBM Reform Act to reform the...

WASHINGTON, DC – During a full committee markup , the House Energy and Commerce Committee advanced budget reconciliation language...

President Trump this week signed an executive order that revived a drug pricing policy, known as the “most favored nation” policy, that...

The White House issued an  executive order  (EO) on April 15 aimed at “Lowering Drug Prices by Once Again Putting Americans First.” The...

Many Congressional leaders and stakeholders continue to highlight the need for the PBM reforms. Representative Buddy Carter (R-GA)...

Representatives Mariannette Miller-Meeks, M.D. (R-IA), Nannette Barragan (D-CA), Nicole Malliotakis (R-NY), Brad Schneider (D-IL), Rick...

Senators Grassley and Cantwell Continue Efforts to Ensure Patients, Employers and Unions No Longer Overpay for Prescriptions Feb. 13,...

California Governor Gavin Newsom (D) has vetoed CA SB966 , legislation which would increase transparency and accountability of pharmacy...

The Federal Trade Commission last week filed a suit accusing the three largest pharmacy benefit managers, or PBMs, of using their market...

The Federal Trade Commission on July 9 issued its interim report on prescription drug middlemen known as pharmacy benefit managers or...

Bipartisan legislation will help lower seniors’ costs for prescription drugs Today, U.S. Senators Ron Wyden (D-OR) and Mike Crapo (R-ID)...

Momentum Continues Building in Support of PBM Reforms to Lower Prescription Drug Costs   The White House held a roundtable discussion...